Lopes Kubitza Fernanda Maria, Anthony James Mudie George
Campos de Santo Antonio, Itu, São Paulo, Brazil.
Red Bank Veterinary Hospital, Dentistry and Oral Surgery, Red Bank, NJ, USA.
J Feline Med Surg. 2019 Dec;21(12):1141-1148. doi: 10.1177/1098612X18820734. Epub 2019 Jan 17.
The aim of this study was to evaluate the outcomes of the treatment of chronic periodontal disease with an oral application of tetradecanol complex (1-TDC) in cats.
The test group (n = 9) received 1-TDC (525 mg per gel capsule/day) and the placebo group (n = 4) received olive oil (0.25 ml per gel capsule/day) for 6 weeks.
Oral treatment with 1-TDC resulted in significant reductions in all parameters of clinical periodontal disease except tooth mobility at 6 weeks. The 1-TDC group exhibited a statistically significant reduction in pocket depth, clinical attachment loss, gingival index and bleeding on probing after treatment at 6 weeks, whereas the placebo group did not show any significant change.
Chronic inflammation associated with periodontal diseases leads to periodontal tissue destruction. As a result, modulation of the host response has been included in the treatment protocol for periodontal diseases. Fatty acids present anti-inflammatory properties and are being investigated for use in the treatment and prevention of progressive periodontal diseases.
本研究旨在评估口服十四烷醇复合物(1-TDC)治疗猫慢性牙周病的效果。
试验组(n = 9)接受1-TDC(每粒凝胶胶囊525毫克/天),安慰剂组(n = 4)接受橄榄油(每粒凝胶胶囊0.25毫升/天),为期6周。
口服1-TDC导致除6周时牙齿松动外,临床牙周病的所有参数均显著降低。1-TDC组在治疗6周后,牙周袋深度、临床附着丧失、牙龈指数和探诊出血均有统计学意义的显著降低,而安慰剂组未显示任何显著变化。
与牙周病相关的慢性炎症会导致牙周组织破坏。因此,调节宿主反应已被纳入牙周病的治疗方案。脂肪酸具有抗炎特性,正在研究其用于治疗和预防进展性牙周病。